Clinical Use of Ultrasensitive Cardiac Troponin I Assay in Intermediate- and High-Risk Surgery Patients

<table>Primary endpoint (%) according to the combination of preoperative N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels less than (−) or greater than (+) 917 pg/mL and postoperative cardiac troponin I (cTnI) peak levels less than (−) or greater than (+) 0.04 <i>μ</i>g/L during the 30-day postoperative follow-up period.</table>

Disease Markers

fig3

Figure 3

Figure 3: Clinical Use of Ultrasensitive Cardiac Troponin I Assay in Intermediate- and High-Risk Surgery Patients 